Actualización en insuficiencia mitral funcional: una revisión integral

  • René Ricardo Rodríguez Olivares Cardiología clínica. Instituto Nacional Cardiovascular - INCOR EsSalud, Lima, Perú.
  • José María Carrasco-Rueda Cardiología clínica. Instituto Nacional Cardiovascular - INCOR EsSalud, Lima; Perú.
  • José Luis Añorga Ocmin Médico Residente de Cardiología - Instituto Nacional Cardiovascular INCOR, Lima, Perú
  • Carlos Lobato-Jeri Médico Residente de Cardiología - Instituto Nacional Cardiovascular INCOR, Lima, Perú
Palabras clave: insuficiencia de la vávula mitral, insuficiencia cardiaca, disfunción ventricular, ecocardiografía

Resumen

Los avances en el manejo de la insuficiencia mitral (IM) funcional en las últimas décadas, hacen que el conocimiento de la misma sea de suma importancia para el cardiólogo clínico, al tener una prevalencia cada vez mayor en pacientes mayores de 50 años. Esta revisión tiene como objetivo dar a conocer de una manera integral las bases fisiopatológicas de la IM para diferenciar sus mecanismos, y correlacionarlos con los hallazgos clínicos, hemodinámicos y de imágenes que valoran la severidad de la enfermedad. Estos datos son relevantes para la adecuada selección del paciente y del momento oportuno de las intervenciones terapéuticas, lo cual involucra a un equipo multidisciplinario en la toma de decisiones para lograr el mayor beneficio dentro de las opciones de tratamiento de esta patología.

Descargas

La descarga de datos todavía no está disponible.

Citas

Del Forno B, De Bonis M, Agricola E, et al. Mitral valve regurgitation: a disease with a wide spectrum of therapeutic options [published online ahead of print, 2020 Jun 29]. Nat Rev Cardiol. 2020;10.1038/s41569-020-0395-7. DOI:10.1038/s41569-020-0395-7

Shah T, Zhong M, Minutello RM. Functional Mitral Regurgitation in Heart Failure [published correction appears in Cardiol Rev. 2020 Jan/Feb;28(1):52]. Cardiol Rev. 2019;27(6):327-36. DOI: 10.1097/crd.0000000000000269

Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11. DOI: 10.1016/S0140-6736(06)69208-8

De Marchena E, Badiye A, Robalino G, et al. Respective prevalence of the different carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development. J Card Surg. 2011;26(4):385-92. doi:10.1111/j.1540-8191.2011.01274.x

Andell P, Li X, Martinsson A, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart. 2017;103(21): 1696–703. DOI: 10.1136/heartjnl-2016-310894

Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25):e1159-e95. DOI:10.1161/CIR.0000000000000503

Comín J, Manito N, Roca J, et al. Insuficiencia mitral funcional. Fisiopatología e impacto del tratamiento médico y de las técnicas quirúrgicas de reducción ventricular izquierda. Rev Española Cardiol. 1999;52(7):512–20. DOI: 10.1016/S0300-8932(99)74959-6

Agricola E, Oppizzi M, Pisani M, et al. Ischemic mitral regurgitation: Mechanisms and echocardiographic classification. Eur J Echocardiogr. 2008;9(2):207–21. DOI: 10.1016/j.euje.2007.03.034

Rodríguez-Roda J, Ruiz M, Rodríguez-Abella H, et al. Situaciones Especiales. Insuficiencia Mitral Isquémica. Cir. Cardiov. 2010;17(4):337-44. DOI: 10.1016/S1134-0096(10)70084-X

Varma PK, Krishna N, Jose RL, et al. Ischemic mitral regurgitation. Ann Card Anaesth. 2017;20(4):432-439. DOI:10.4103/aca.ACA_58_17

Hung JW. Ischemic (functional) mitral regurgitation. Cardiol Clin 2013;31(2):231-236. DOI: 10.1016/j.ccl.2013.04.003

Borger MA, Alam A, Murphy PM, et al. Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann Thorac Surg. 2006;81(3):1153-1161. DOI: 10.1016/j.athoracsur.2005.08.080

Messas E, Guerrero JL, Handschumacher MD, et al. Paradoxic decrease in ischemic mitral regurgitation with papillary muscle dysfunction: Insights from three-dimensional and contrast echocardiography with strain rate measurement. Circulation. 2001;104(16):1952–7. DOI: 10.1161/hc4101.097112

Otsuji Y, Handschumacher MD, Liel-Cohen N, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: Three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol. 2001;37(2):641–8. DOI: 10.1016/s0735-1097(00)01134-7

Lancellotti P, Dulgheru R, Marchetta S, et al. Valve Disease in Heart Failure: Secondary but Not Irrelevant. Heart Fail Clin. 2019;15(2):219-27. DOI:10.1016/j.hfc.2018.12.014

He S, Fontaine AA, Schwammenthal E, et al. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation. 1997;96(6):1826-34. DOI: 10.1161/01.cir.96.6.1826

Watanabe N, Ogasawara Y, Yamaura Y, et al. Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography. J Am Coll Cardiol. 2005;45(5):763–9. DOI: 10.1016/j.jacc.2004.11.048

Chaput M, Handschumacher MD, Tournoux F, et al. Mitral leaflet adaptation to ventricular remodeling occurrence and adequacy in patients with functional mitral regurgitation. Circulation. 2008;118(8):845–52. DOI: 10.1161/CIRCULATIONAHA.107.749440.

Dal-Bianco JP, Aikawa E, Bischoff J, et al. Active adaptation of the tethered mitral valve: Insights into a compensatory mechanism for functional mitral regurgitation. Circulation. 2009;120(4):334–42. DOI: 10.1161/CIRCULATIONAHA.108.846782

Inciardi RM, Rossi A, Benfari G, et al. Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis. Curr Heart Fail Rep. 2018;15(2):106–15. DOI: 10.1007/s11897-018-0379-7

Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303-71. DOI: http://dx.doi.org/10.1016/j.echo.2017.01.007

Srichai MB, Grimm RA, Stillman AE, et al. Ischemic mitral regurgitation: impact of the left ventricle and mitral valve in patients with left ventricular systolic dysfunction. Ann Thorac Surg. 2005;80(1):170-8. DOI: 10.1016/j.athoracsur.2005.01.068

Otsuji Y, Handschumacher MD, Schwammenthal E, et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation. 1997 Sep 16;96(6):1999-2008. DOI: doi.org/10.1161/01.CIR.96.6.1999

Uretsky S, Gillam L, Lang R, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol. 2015;65(11):1078-88. DOI: 10.1016/j.jacc.2014.12.047

Essayagh B, Iacuzio L, Civaia F, Avierinos JF, Tribouilloy C, Levy F. Usefulness of 3-Tesla Cardiac Magnetic Resonance to Detect Mitral Annular Disjunction in Patients with Mitral Valve Prolapse. Am J Cardiol. 2019;124(11):1725-30. DOI:10.1016/j.amjcard.2019.08.047

Han Y, Peters D, Salton C, et al. Cardiovascular Magnetic Resonance Characterization of Mitral Valve Prolapse. JACC Cardiovasc Imaging. 2008;1(3):294-303. DOI:10.1016/j.jcmg.2008.01.013

Miller MA, Dukkipati SR, Turagam M, Liao SL, Adams DH, Reddy VY. Arrhythmic Mitral Valve Prolapse: JACC Review Topic of the Week. J Am Coll Cardiol. 2018;72(23 Pt A):2904-14. DOI:10.1016/j.jacc.2018.09.048

Bonow RO, O'Gara PT, Adams DH, et al. 2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Solution Set Oversight Committee [published correction appears in J Am Coll Cardiol. 2020 Jun 16;75(23):3000]. J Am Coll Cardiol. 2020;75(17):2236-70. DOI:10.1016/j.jacc.2020.02.005

Nishino S, Watanabe N, Ashikaga K, et al. Reverse Remodeling of the mitral valve complex after radiofrequency catheter ablation for atrial fibrillation: A Serial 3-Dimensional Echocardiographic Study. Circ Cardiovasc Imaging. 2019;12(10): e009317. DOI: 10.1161/circimaging.119.009317

Boltwood CM Jr, Shah PM. Secondary Mitral Regurgitation. J Am Coll Cardiol. 2015;66(17):1946-47. DOI: 10.1016 / j.jacc.2015.07.078

Comin-Colet J, Sánchez-Corral MA, Manito N, et al. Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction. Transplant Proc. 2002;34(1):177-8. DOI: 10.1016/s0041-1345(01)02717-8

Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol. 1999;83(8):1201-05. DOI: 10.1016/s0002-9149(99)00059-4

Waagstein F, Stromblad O, Andersson B, et al. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2003;5(5):679–91. DOI: 10.1016/s1388-9842(03)00105-3

Kang D-H, Park S-J, Shin S-H, Hong GR, Lee S, Kim MS, et al. Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation. Circulation. 2019;139(11):1354–65. DOI:10. 1161/CIRCULATIONAHA.118.037077.

Levine AB, Muller C, Levine TB. Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling. Am J Cardiol. 1998;82(10):1299–30. DOI: 10.1016/s0002-9149(98)00623-7

St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107(15):1985-90.DOI: 10.1161/01.CIR.0000065226.24159.E9

Cleland J, Freemantle N, Ghio S, et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality rom baseline variables and the early response. A report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol. 2008;52(6): 438–45. DOI: 10.1016 / j.jacc.2008.04.036.

Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873–80. DOI: 10.1056/NEJM200103223441202

Sitges M, Vidal B, Delgado V, et al. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. Am J Cardiol. 2009;104(3):383–8. DOI: 10.1016/j.amjcard.2009.03.060

Cabrera-Bueno F, Molina-Mora MJ, Alzueta J, et al. Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy. Eur J Echocardiogr. 2010;11(2):131–7. DOI: 10.1093/ejechocard/jep184.

Di Biase L, Auricchio A, Mohanty P, et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace. 2011;13 (6):829–38. DOI: 10.1093/europace/eur047

Regueiro A, Granada JF, Dagenais F, Rodés-Cabau J. Transcatheter Mitral Valve Replacement: Insights From Early Clinical Experience and Future Challenges. J Am Coll Cardiol. 2017;69(17):2175-92. DOI: 10.1016/j.jacc.2017.02.045

Nappi F, Avtaar Singh SS, Padala M, et al. The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function. Ann Thorac Surg. 2019;108(6):1901-12. DOI: 10.1016/j.athoracsur.2019.06.039

Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair, J Am Coll Cardiol. 2015;66(25) :2844-54 DOI: 10.1056/NEJMoa1805374

Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. N Engl J Med. 2018 ;379(24) 2297-30. DOI: 10.1056/NEJMoa1805374

Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018;379(24):2307-18. DOI: 10.1056/NEJMoa1806640

Chan KM, Punjabi PP, Flather M, et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012;126(21): 2502–10. DOI: 10.1161/CIRCULATIONAHA.112.143818

Kon MW, Myerson SG, Moat NE, et al. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis. 2004;13(4):600–7. PMID: 15311866

Aphram G, De Kerchove L, Mastrobuoni S, et al. Re- repair of the failed mitral valve: insights into aetiology and surgical management. Eur. J. Cardiothorac Surg. 2018; 54(4): 774–80. DOI: 10.1093/ejcts/ezy111.

Publicado
2020-09-16
Cómo citar
1.
Rodríguez Olivares RR, Carrasco-Rueda JM, Añorga Ocmin JL, Lobato-Jeri C. Actualización en insuficiencia mitral funcional: una revisión integral. Arch Peru Cardiol Cir Cardiovasc [Internet]. 16 de septiembre de 2020 [citado 6 de diciembre de 2021];1(3):165 -175. Disponible en: https://apcyccv.org.pe/index.php/apccc/article/view/70
Sección
Artículos de revisión

Artículos más leídos del mismo autor/a